Try our mobile app
#reports #RICK
[RCI Hospitality](https://eninvs.com/all.php?name=RICK) (Restaurants) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191859)
(2025-07-10, Before Market Open):
- Revenue -6.6% YoY (vs -8.3% in previous quarter and historical rate +24.2%)
- EBITDA margin 18.3% increased compared to 1.3% same period last year
- Net Debt increased by $5 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0 bln (positive), 2.0% of market cap
- EV/EBITDA multiple is 12x compared to historical level (75th percentile) of 17.7x
- EV/Sales multiple is 2.1x
At the opening of the session the share price went down -0.2% vs S&P500 +0.1%
------------------------------------------------
#reports #VNRX
[VolitionRx Limited](https://eninvs.com/all.php?name=VNRX) (Diagnostics and Research) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191820)
(2025-08-13, After Market Close):
- Revenue +2.8% YoY (vs +43.0% in previous quarter and historical rate +117.8%)
- EBITDA margin -1485.3% increased compared to -1697.2% same period last year
- Net Debt increased by $4.6 bln since the start of the year (6822.9% of market cap)
- FCF (LTM) -$4.8 bln (negative), 7220.9% of market cap
- EV/Sales multiple is 6.2x
At the opening of the session the share price went up +8.1% vs S&P500 -0.2%
------------------------------------------------
#reports #INTZ
[Intrusion](https://eninvs.com/all.php?name=INTZ) (Software — Infrastructure) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191824)
(2025-08-12, After Market Close):
- Revenue +100% YoY (vs +100.0% in previous quarter and historical rate +16.7%)
- EBITDA margin -100.0% has not changed compared to -100.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (71.6% of market cap)
- FCF (LTM) +$0 bln (positive), 143.1% of market cap
- EV/Sales multiple is 0.1x
At the opening of the session the share price went up +2.6% vs S&P500 +0.3%
------------------------------------------------
#reports #DAN
[Dana](https://eninvs.com/all.php?name=DAN) (Auto Parts) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191814)
(2025-08-04, Before Market Open):
- Revenue -29.3% YoY (vs -14.0% in previous quarter and historical rate -0.9%)
- EBITDA -57.4% YoY (vs -1.7% in previous quarter and historical rate +0.3%)
- EBITDA margin 4.8% decreased compared to 7.9% same period last year
- Net Debt increased by $340 mln over the past reporting period (12.7% of market cap)
- FCF (LTM) +$1518.1 bln (positive), 56635.1% of market cap
- EV/EBITDA multiple is 11.2x compared to historical level (75th percentile) of 8.1x
- EV/Sales multiple is 0.6x
At the opening of the session the share price went up +1.9% vs S&P500 +0.5%
------------------------------------------------
#reports #ADES
[Advanced Emissions Solutions](https://eninvs.com/all.php?name=ADES) (Pollution and Treatment Controls) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191778)
(2023-11-08, After Market Close):
- Revenue +16% YoY (vs +22.7% in previous quarter and historical rate +20.7%)
- EBITDA +50% YoY (vs +200.0% in previous quarter)
- EBITDA margin 10.3% increased compared to 8.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0 bln (negative), 20.9% of market cap
- EV/EBITDA multiple is 20.1x compared to historical level (75th percentile) of 29.3x
- EV/Sales multiple is 0.8x
At the opening of the session the share price went up +0.5%
------------------------------------------------
#reports #YMAB
[Y-mAbs Therapeutics](https://eninvs.com/all.php?name=YMAB) (Therapeutic drug developer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191744)
(2025-08-07, Before Market Open):
- Revenue -13% YoY (vs +5.0% in previous quarter and historical rate +39.0%)
- EBITDA margin -30.0% increased compared to -43.5% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0 bln (negative), 4.5% of market cap
- EV/Sales multiple is 3.7x
------------------------------------------------
#reports #XBIO
[Xenetic Biosciences](https://eninvs.com/all.php?name=XBIO) (Biotechnology) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191740)
(2025-08-12, Before Market Open):
- Revenue -18.7% YoY (vs +16.0% in previous quarter and historical rate +61.0%)
- EBITDA margin 68.3% increased compared to -28.9% same period last year
- Net Debt increased by $384 mln over the past reporting period (8706.5% of market cap)
- FCF (LTM) -$2.1 bln (negative), 48407.0% of market cap
- EV/EBITDA multiple is 9.3x compared to historical level (75th percentile) of 4.7x
- EV/Sales multiple is -2x
------------------------------------------------
#reports #UTMD
[Utah Medical Products](https://eninvs.com/all.php?name=UTMD) (Medical Instruments and Supplies) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191732)
(2025-05-15, Before Market Open):
- Revenue 0% YoY (vs -9.1% in previous quarter and historical rate +3.0%)
- EBITDA 0% YoY (vs -20.0% in previous quarter and historical rate -4.2%)
- EBITDA margin 40.0% has not changed compared to 40.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.3 bln (positive), 149.6% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 12.6x
- EV/Sales multiple is 3.1x
At the opening of the session the share price went up +1.7% vs S&P500 -0.4%
------------------------------------------------
#reports #URGN
[UroGen Pharma](https://eninvs.com/all.php?name=URGN) (Biotechnology) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191727)
(2025-08-07, Before Market Open):
- Revenue +9.1% YoY (vs +5.3% in previous quarter and historical rate +18.5%)
- EBITDA margin -170.8% decreased compared to -118.2% same period last year
- Net Debt increased by $40 mln over the past reporting period (4.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 7.7% of market cap
- EV/Sales multiple is 9.6x
At the opening of the session the share price went down -3.4% vs S&P500 +0.5%
------------------------------------------------
#reports #TPIC
[TPI Composites](https://eninvs.com/all.php?name=TPIC) (Industrial company) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191721)
(2025-08-04, After Market Close):
- Revenue -11% YoY (vs +12.4% in previous quarter and historical rate -6.9%)
- EBITDA margin -11.6% decreased compared to -9.7% same period last year
- Net Debt increased by $61 mln over the past reporting period (545.8% of market cap)
- FCF (LTM) +$0 bln (positive), 241.6% of market cap
- EV/Sales multiple is 0.5x
At the opening of the session the share price went up +0.2% vs S&P500 +0.1%
------------------------------------------------
#reports #SYPR
[Sypris Solutions](https://eninvs.com/all.php?name=SYPR) (Auto Parts) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191713)
(2025-08-12, Before Market Open):
- Revenue -13.9% YoY (vs -16.7% in previous quarter and historical rate +7.8%)
- EBITDA -150% YoY (vs 0.0% in previous quarter)
- EBITDA margin -3.2% decreased compared to 5.6% same period last year
- Net Debt decreased by $1 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0 bln (negative), 21.2% of market cap
- EV/EBITDA multiple is 10.7x compared to historical level (75th percentile) of 12.3x
- EV/Sales multiple is 0.4x
At the opening of the session the share price went down -1.5% vs S&P500 +0.3%
------------------------------------------------
#reports #STE
[STERIS](https://eninvs.com/all.php?name=STE) (Medical equipment supplier) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191710)
(2025-08-06, After Market Close):
- Revenue +8.7% YoY (vs +4.4% in previous quarter and historical rate +5.4%)
- EBITDA +43.1% YoY (vs -1.8% in previous quarter and historical rate +17.3%)
- EBITDA margin 26.2% increased compared to 19.9% same period last year
- Net Debt decreased by $205 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 15.5x compared to historical level (75th percentile) of 25.1x
- EV/Sales multiple is 4.3x
At the opening of the session the share price went up +2.7% vs S&P500 +0.5%
------------------------------------------------
#reports #SRTS
[Sensus Healthcare](https://eninvs.com/all.php?name=SRTS) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191708)
(2025-08-07, After Market Close):
- Revenue -22.2% YoY (vs -27.3% in previous quarter and historical rate +18.5%)
- EBITDA -200% YoY (vs -200.0% in previous quarter)
- EBITDA margin -28.6% decreased compared to 22.2% same period last year
- Net Debt decreased by $4 mln over the past reporting period (7.3% of market cap)
- FCF (LTM) +$0 bln (positive), 7.3% of market cap
- EV/Sales multiple is 0.9x
At the opening of the session the share price went down -35.7% vs S&P500 +0.2%
------------------------------------------------
#reports #SEAS
[SeaWorld Entertainment](https://eninvs.com/all.php?name=SEAS) (Theme park owner) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191704)
(2023-11-08, Before Market Open):
- Revenue -1.6% YoY (vs -3.4% in previous quarter and historical rate +1.0%)
- EBITDA -10.7% YoY (vs -3.3% in previous quarter and historical rate +11.0%)
- EBITDA margin 37.3% decreased compared to 41.2% same period last year
- Net Debt decreased by $122 mln over the past reporting period (4.4% of market cap)
- EV/EBITDA multiple is 8.2x compared to historical level (75th percentile) of 8.7x
- EV/Sales multiple is 2.9x
At the opening of the session the share price went up +1.7%
------------------------------------------------
#reports #SBH
[Sally Beauty](https://eninvs.com/all.php?name=SBH) (Professional cosmetics supplier ) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191702)
(2025-08-05, Before Market Open):
- Revenue -1% YoY (vs -2.8% in previous quarter and historical rate -1.3%)
- EBITDA +3% YoY (vs 0.0% in previous quarter and historical rate +0.9%)
- EBITDA margin 11.0% increased compared to 10.6% same period last year
- Net Debt decreased by $32 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 6.9% of market cap
- EV/EBITDA multiple is 6.8x compared to historical level (75th percentile) of 8x
- EV/Sales multiple is 0.7x
At the opening of the session the share price went up +10.5% vs S&P500 +0.1%
------------------------------------------------
#reports #RKDA
[Arcadia Biosciences](https://eninvs.com/all.php?name=RKDA) (Agricultural Inputs) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191697)
(2023-08-10, After Market Close):
- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate -17.4%)
- EBITDA margin -100.0% has not changed compared to -100.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (15.7% of market cap)
- FCF (LTM) -$0 bln (negative), 63.0% of market cap
- EV/EBITDA multiple is 2.4x compared to historical level (75th percentile) of 1x
- EV/Sales multiple is 0.5x
At the opening of the session the share price went up +4.5%
------------------------------------------------
#reports #RHE
[Regional Health Properties](https://eninvs.com/all.php?name=RHE) (Medical Care Facilities) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191695)
(2025-04-03):
- Revenue +150% YoY (vs +75.0% in previous quarter and historical rate +16.5%)
- Net Debt decreased by $1 mln over the past reporting period (20377.5% of market cap)
- FCF (LTM) -$0 bln (negative), 122264.8% of market cap
- EV/EBITDA multiple is 34x compared to historical level (75th percentile) of 17.5x
- EV/Sales multiple is 1.3x
------------------------------------------------
#reports #RGNX
[REGENXBIO](https://eninvs.com/all.php?name=RGNX) (Developer of viral gene therapy) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191692)
(2025-08-07, Before Market Open):
- Revenue -4.5% YoY (vs +456.3% in previous quarter and historical rate -1.0%)
- EBITDA margin -281.0% decreased compared to -236.4% same period last year
- Net Debt decreased by $58 mln over the past reporting period (12.8% of market cap)
- FCF (LTM) -$0 bln (negative), 3.8% of market cap
- EV/Sales multiple is 1.3x
At the opening of the session the share price went down -2.8% vs S&P500 +0.5%
------------------------------------------------
#reports #PRPO
[Precipio](https://eninvs.com/all.php?name=PRPO) (Diagnostics and Research) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191687)
(2023-11-13, After Market Close):
- Revenue +20% YoY (vs +66.7% in previous quarter and historical rate +55.8%)
- EBITDA margin -16.7% increased compared to -20.0% same period last year
- EV/Sales multiple is 17.1x
At the opening of the session the share price went down -7.1%
------------------------------------------------
#reports #POWI
[Power Integrations](https://eninvs.com/all.php?name=POWI) (Analog integrated circuits manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191685)
(2025-08-06, After Market Close):
- Revenue +9.4% YoY (vs +15.2% in previous quarter and historical rate -12.9%)
- EBITDA -45.5% YoY (vs +40.0% in previous quarter and historical rate -31.0%)
- EBITDA margin 5.2% decreased compared to 10.4% same period last year
- Net Debt increased by $20 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 45.5x compared to historical level (75th percentile) of 57.4x
- EV/Sales multiple is 5.3x
At the opening of the session the share price went down -14.9% vs S&P500 +0.5%
------------------------------------------------
#reports #POLA
[Polar Power](https://eninvs.com/all.php?name=POLA) (Electrical Equipment and Parts) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191681)
(2024-11-15, After Market Close):
- Revenue -40% YoY (vs 0.0% in previous quarter and historical rate +2.1%)
- EV/Sales multiple is 0.9x
At the opening of the session the share price went up +599.7% vs S&P500 +0.2%
------------------------------------------------
#reports #PENN
[Penn National Gaming](https://eninvs.com/all.php?name=PENN) (Provider of entertainment services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191678)
(2025-08-07, Before Market Open):
- Revenue +6.1% YoY (vs +4.1% in previous quarter and historical rate +2.7%)
- EBITDA +2.2% YoY (vs +73.6% in previous quarter and historical rate -4.5%)
- EBITDA margin 10.7% decreased compared to 11.1% same period last year
- Net Debt increased by $15 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.0% of market cap
- EV/EBITDA multiple is 18.9x compared to historical level (75th percentile) of 13.8x
- EV/Sales multiple is 1.6x
At the opening of the session the share price went up +1.3% vs S&P500 +0.5%
------------------------------------------------
#reports #NUWE
[Nuwellis](https://eninvs.com/all.php?name=NUWE) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191669)
(2023-05-09):
- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +1.4%)
- EBITDA margin -150.0% decreased compared to -100.0% same period last year
- Net Debt increased by $14 mln over the past reporting period (57.8% of market cap)
- FCF (LTM) +$0 bln (positive), 37.1% of market cap
- EV/Sales multiple is 5.4x
------------------------------------------------
#reports #NRG
[NRG Energy](https://eninvs.com/all.php?name=NRG) (Energy services provider) reported for 2025 q2
(2025-08-06, Before Market Open):
- Revenue +1.2% YoY (vs +15.6% in previous quarter and historical rate +5.0%)
- EBITDA -79.7% YoY (vs +28.1% in previous quarter and historical rate +15.5%)
- EBITDA margin 5.1% decreased compared to 25.5% same period last year
- Net Debt increased by $1.1 bln since the start of the year (3.0% of market cap)
- FCF (LTM) -$0.5 bln (negative), 1.4% of market cap
- EV/EBITDA multiple is 19.8x compared to historical level (75th percentile) of 12.1x
- EV/Sales multiple is 1.6x
At the opening of the session the share price went down -3.4% vs S&P500 +0.2%
------------------------------------------------
#reports #NEPH
[Nephros](https://eninvs.com/all.php?name=NEPH) (Medical Instruments and Supplies) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191663)
(2025-08-07, After Market Close):
- Revenue +33.3% YoY (vs +25.0% in previous quarter and historical rate +23.6%)
- Net Debt decreased by $1 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0 bln (positive), 2.2% of market cap
- EV/EBITDA multiple is 40.1x compared to historical level (75th percentile) of 34x
- EV/Sales multiple is 2.4x
At the opening of the session the share price went up +17.6% vs S&P500 +0.2%
------------------------------------------------
#reports #MYSZ
[My Size](https://eninvs.com/all.php?name=MYSZ) (Software — Application) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191659)
(2022-11-17):
- Revenue 0% YoY (vs -66.7% in previous quarter and historical rate +72.2%)
- EBITDA margin -50.0% has not changed compared to -50.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (40.1% of market cap)
- FCF (LTM) -$0 bln (negative), 120.4% of market cap
- EV/Sales multiple is -0.3x
------------------------------------------------
#reports #MASS
[908 Devices Inc.](https://eninvs.com/all.php?name=MASS) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191647)
(2025-08-05, Before Market Open):
- Revenue -7.1% YoY (vs +20.0% in previous quarter and historical rate +20.6%)
- EBITDA margin -107.7% decreased compared to -92.9% same period last year
- Net Debt increased by $7 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) +$0 bln (positive), 20.0% of market cap
- EV/Sales multiple is 1.9x
At the opening of the session the share price went down -1.1% vs S&P500 +0.1%
------------------------------------------------
#reports #KPTI
[Karyopharm Therapeutics](https://eninvs.com/all.php?name=KPTI) (Biotechnology) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191644)
(2025-08-11, Before Market Open):
- Revenue -11.6% YoY (vs -9.1% in previous quarter and historical rate -10.5%)
- EBITDA margin -65.8% increased compared to -67.4% same period last year
- Net Debt increased by $22 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 10.0% of market cap
- EV/Sales multiple is 6.3x
At the opening of the session the share price went up +1.5% vs S&P500 0.0%
------------------------------------------------
#reports #IAS
[Integral Ad Science Holding Corp.](https://eninvs.com/all.php?name=IAS) (Advertising Agencies) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191630)
(2025-08-07, After Market Close):
- Revenue +15.5% YoY (vs +16.5% in previous quarter and historical rate +15.7%)
- EBITDA +26.7% YoY (vs +75.0% in previous quarter and historical rate +40.6%)
- EBITDA margin 25.5% increased compared to 23.3% same period last year
- Net Debt decreased by $42 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.9% of market cap
- EV/EBITDA multiple is 9.8x compared to historical level (75th percentile) of 39.4x
- EV/Sales multiple is 2.5x
At the opening of the session the share price went up +3.6% vs S&P500 +0.2%
------------------------------------------------
#reports #HYFM
[Hydrofarm Holdings Group, Inc.](https://eninvs.com/all.php?name=HYFM) (Farm and Heavy Construction Machinery) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191627)
(2025-08-12):
- Revenue -29.1% YoY (vs -24.1% in previous quarter and historical rate -27.8%)
- EBITDA margin -28.2% increased compared to -30.9% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 4.8% of market cap
- EV/EBITDA multiple is 45.1x compared to historical level (75th percentile) of 164x
- EV/Sales multiple is 2.2x
At the opening of the session the share price went up +6.0% vs S&P500 +0.3%
------------------------------------------------
#reports #FWRD
[Forward Air](https://eninvs.com/all.php?name=FWRD) (Transportation services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191620)
(2025-07-31, After Market Close):
- Revenue -3.9% YoY (vs +13.1% in previous quarter and historical rate +15.8%)
- EBITDA margin 9.0% increased compared to -162.6% same period last year
- Net Debt increased by $23 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) -$0.1 bln (negative), 6.5% of market cap
- EV/EBITDA multiple is 11.2x compared to historical level (75th percentile) of 15.3x
- EV/Sales multiple is 1.2x
At the opening of the session the share price went down -3.5% vs S&P500 -0.8%
------------------------------------------------
#reports #FTEK
[Fuel Tech](https://eninvs.com/all.php?name=FTEK) (Pollution and Treatment Controls) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191618)
(2025-08-05, After Market Close):
- Revenue -14.3% YoY (vs +20.0% in previous quarter and historical rate +0.2%)
- EBITDA margin -16.7% decreased compared to -14.3% same period last year
- Net Debt decreased by $1 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0 bln (positive), 2.3% of market cap
- EV/Sales multiple is 2.6x
At the opening of the session the share price went down -11.1% vs S&P500 +0.2%
------------------------------------------------
#reports #FF
[FutureFuel](https://eninvs.com/all.php?name=FF) (Chemicals) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191614)
(2025-08-11, After Market Close):
- Revenue -50% YoY (vs -69.0% in previous quarter and historical rate -15.8%)
- EBITDA -242.9% YoY (vs -420.0% in previous quarter)
- EBITDA margin -27.8% decreased compared to 9.7% same period last year
- Net Debt increased by $4 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) -$0 bln (negative), 8.9% of market cap
- EV/Sales multiple is 0.4x
At the opening of the session the share price went down -1.1% vs S&P500 +0.3%
------------------------------------------------
#reports #FBIOP
[Fortress Biotech](https://eninvs.com/all.php?name=FBIOP) (Biotechnology) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191612):
- Revenue +6.7% YoY (vs 0.0% in previous quarter and historical rate -0.4%)
- EBITDA margin -225.0% decreased compared to -180.0% same period last year
- Net Debt decreased by $5 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0 bln (negative), 7.7% of market cap
- EV/Sales multiple is 3.3x
------------------------------------------------
#reports #ETON
[Eton Pharmaceuticals](https://eninvs.com/all.php?name=ETON) (Biotechnology) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191609)
(2025-08-07, After Market Close):
- Revenue +111.1% YoY (vs +112.5% in previous quarter and historical rate +76.3%)
- Net Debt decreased by $8 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0 bln (negative), 5.7% of market cap
- EV/EBITDA multiple is 154.4x compared to historical level (75th percentile) of 103x
- EV/Sales multiple is 8x
At the opening of the session the share price went up +11.5% vs S&P500 +0.2%
------------------------------------------------
#reports #DT
[Dynatrace](https://eninvs.com/all.php?name=DT) (Software provider) reported for 2025 q2
(2025-08-06, Before Market Open):
- Revenue +19.5% YoY (vs +16.8% in previous quarter and historical rate +21.7%)
- EBITDA +50% YoY (vs +70.3% in previous quarter and historical rate +53.4%)
- EBITDA margin 14.5% increased compared to 11.5% same period last year
- Net Debt decreased by $221 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0.4 bln (positive), 2.6% of market cap
- EV/EBITDA multiple is 49.9x compared to historical level (75th percentile) of 96.9x
- EV/Sales multiple is 7.4x
At the opening of the session the share price went up +0.8% vs S&P500 +0.2%
------------------------------------------------
#reports #DOCS
[Doximity, Inc.](https://eninvs.com/all.php?name=DOCS) (Health Information Services) reported for 2025 q2
(2025-08-07, After Market Close):
- Revenue +15% YoY (vs +16.9% in previous quarter and historical rate +17.8%)
- EBITDA +16.3% YoY (vs +18.2% in previous quarter and historical rate +29.3%)
- EBITDA margin 39.0% increased compared to 38.6% same period last year
- Net Debt increased by $74 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.3 bln (positive), 2.3% of market cap
- EV/EBITDA multiple is 46.1x compared to historical level (75th percentile) of 44.2x
- EV/Sales multiple is 19.4x
At the opening of the session the share price went up +7.6% vs S&P500 +0.2%
------------------------------------------------
#reports #DAIO
[Data I/O Corporation](https://eninvs.com/all.php?name=DAIO) (Electronic Components) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191594)
(2025-07-24, After Market Close):
- Revenue +20% YoY (vs 0.0% in previous quarter and historical rate +1.4%)
- EBITDA margin -16.7% increased compared to -20.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (3.5% of market cap)
- FCF (LTM) -$0 bln (negative), 7.0% of market cap
- EV/Sales multiple is 0.9x
At the opening of the session the share price went down -5.2% vs S&P500 +0.1%
------------------------------------------------
#reports #CLRO
[ClearOne](https://eninvs.com/all.php?name=CLRO) (Communication Equipment) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191586)
(2025-08-12, After Market Close):
- Revenue 0% YoY (vs -50.0% in previous quarter and historical rate -27.3%)
- EBITDA margin -200.0% decreased compared to -150.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) -$0 bln (negative), 2.9% of market cap
- EV/Sales multiple is 10.6x
At the opening of the session the share price went down -0.7% vs S&P500 +0.3%
------------------------------------------------
#reports #CHGG
[Chegg](https://eninvs.com/all.php?name=CHGG) (Learning platform for schoolchildren and students) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191582)
(2025-08-05, After Market Close):
- Revenue -35.6% YoY (vs -30.5% in previous quarter and historical rate -12.7%)
- EBITDA margin -19.0% increased compared to -285.3% same period last year
- Net Debt increased by $3 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) +$0.3 bln (positive), 219.6% of market cap
- EV/Sales multiple is 0.2x
At the opening of the session the share price went down -7.0% vs S&P500 +0.2%
------------------------------------------------
#reports #BKTI
[BK Technologies Corporation](https://eninvs.com/all.php?name=BKTI) (Communication Equipment) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191566)
(2023-05-11, Before Market Open):
- Revenue +5% YoY (vs +5.6% in previous quarter and historical rate +30.2%)
- EBITDA +100% YoY (vs +200.0% in previous quarter)
- EBITDA margin 19.0% increased compared to 10.0% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 84.4x compared to historical level (75th percentile) of 89.4x
- EV/Sales multiple is 14.1x
At the opening of the session the share price went down -2.2%
------------------------------------------------
#reports #BFRI
[Biofrontera Inc.](https://eninvs.com/all.php?name=BFRI) (Drug Manufacturers — Specialty and Generic) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191562)
(2023-08-11, Before Market Open):
- Revenue +12.5% YoY (vs +12.5% in previous quarter and historical rate +30.9%)
- EBITDA margin -55.6% increased compared to -62.5% same period last year
- Net Debt decreased by $6 mln over the past reporting period (24.2% of market cap)
- FCF (LTM) -$0 bln (negative), 24.2% of market cap
- EV/Sales multiple is 0.4x
At the opening of the session the share price went down -1.9%
------------------------------------------------
#reports #BDSX
[Biodesix](https://eninvs.com/all.php?name=BDSX) (Diagnostics and Research) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191560)
(2025-08-07, After Market Close):
- Revenue +11.1% YoY (vs +20.0% in previous quarter and historical rate +30.0%)
- EBITDA margin -40.0% decreased compared to -38.9% same period last year
- Net Debt increased by $6 mln over the past reporting period (10.3% of market cap)
- FCF (LTM) -$0 bln (negative), 44.8% of market cap
- EV/Sales multiple is 1.4x
At the opening of the session the share price went down -8.3% vs S&P500 +0.2%
------------------------------------------------
#reports #BBGI
[Beasley Broadcast Group](https://eninvs.com/all.php?name=BBGI) (Broadcasting) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191559)
(2025-08-12, Before Market Open):
- Revenue -12.3% YoY (vs -10.1% in previous quarter and historical rate -3.6%)
- EBITDA -40.6% YoY (vs -132.6% in previous quarter and historical rate +46.9%)
- EBITDA margin 8.5% decreased compared to 12.5% same period last year
- Net Debt decreased by $5.3 bln since the start of the year (3777.1% of market cap)
- FCF (LTM) -$3.8 bln (negative), 2752.3% of market cap
- EV/EBITDA multiple is 16.8x compared to historical level (75th percentile) of 14.4x
- EV/Sales multiple is 1.2x
At the opening of the session the share price went up +2.5% vs S&P500 +0.3%
------------------------------------------------
#reports #ATNI
[ATN International](https://eninvs.com/all.php?name=ATNI) (Telecommunications company) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191548)
(2025-08-07, After Market Close):
- Revenue -1.1% YoY (vs -4.3% in previous quarter and historical rate +28.3%)
- EBITDA -43.5% YoY (vs -7.3% in previous quarter and historical rate +12.1%)
- EBITDA margin 19.3% decreased compared to 33.9% same period last year
- Net Debt increased by $6 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$0 bln (positive), 1.7% of market cap
- EV/EBITDA multiple is 15.5x compared to historical level (75th percentile) of 10.7x
- EV/Sales multiple is 0.8x
At the opening of the session the share price went down -0.1% vs S&P500 +0.2%
------------------------------------------------
#reports #AKA
[a.k.a. Brands Holding Corp.](https://eninvs.com/all.php?name=AKA) (Internet Retail) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191533)
(2023-11-08, After Market Close):
- Revenue +403.1% YoY (vs +10.3% in previous quarter and historical rate +6.7%)
- EBITDA -60% YoY (vs -200.0% in previous quarter)
- EBITDA margin 2.5% decreased compared to 31.3% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0 bln (negative), 1.2% of market cap
- EV/EBITDA multiple is 140x compared to historical level (75th percentile) of 192.4x
- EV/Sales multiple is 2.6x
At the opening of the session the share price went down -9.9%
------------------------------------------------
#reports #AGEN
[Agenus](https://eninvs.com/all.php?name=AGEN) (Biotechnology) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191530)
(2025-08-11, Before Market Open):
- Revenue +8.3% YoY (vs -14.3% in previous quarter and historical rate +9.1%)
- EBITDA margin -53.8% increased compared to -112.5% same period last year
- Net Debt increased by $8 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 5.1% of market cap
- EV/Sales multiple is 18.9x
At the opening of the session the share price went down -7.9% vs S&P500 0.0%
------------------------------------------------
#reports #ZI
@ saas
[ZoomInfo Technologies](https://eninvs.com/all.php?name=ZI) (Software developer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191746)
(2025-05-12, After Market Close):
- Revenue +5.1% YoY (vs -1.3% in previous quarter and historical rate +10.9%)
- EBITDA +470.6% YoY (vs +17.5% in previous quarter and historical rate +34.7%)
- EBITDA margin 31.6% increased compared to 5.8% same period last year
- Net Debt increased by $121 mln over the past reporting period (3.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 4.0% of market cap
- EV/EBITDA multiple is 13.5x compared to historical level (75th percentile) of 32.8x
- EV/Sales multiple is 4.2x
At the opening of the session the share price went down -9.9% vs S&P500 +0.2%
------------------------------------------------
#reports #RPD
@ saas
[Rapid7](https://eninvs.com/all.php?name=RPD) (Analytical software provider) reported for 2025 q2
(2025-08-07, After Market Close):
- Revenue +2.9% YoY (vs +2.4% in previous quarter and historical rate +11.8%)
- EBITDA -16.7% YoY (vs -45.5% in previous quarter and historical rate +60.4%)
- EBITDA margin 7.0% decreased compared to 8.7% same period last year
- Net Debt decreased by $65 mln over the past reporting period (4.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 9.0% of market cap
- EV/EBITDA multiple is 25.5x compared to historical level (75th percentile) of 52.9x
- EV/Sales multiple is 2.1x
At the opening of the session the share price went down -1.2% vs S&P500 +0.2%
------------------------------------------------
#reports #BEEM
@ renewable-energy
[Beam Global](https://eninvs.com/all.php?name=BEEM) (Solar) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191561)
(2025-08-13, After Market Close):
- Revenue -53.3% YoY (vs -60.0% in previous quarter and historical rate +69.9%)
- EBITDA margin -57.1% decreased compared to -26.7% same period last year
- Net Debt decreased by $1 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) -$0 bln (negative), 14.4% of market cap
- EV/Sales multiple is 1x
------------------------------------------------
#reports #TTWO
@ gaming
[Take-Two Interactive Software](https://eninvs.com/all.php?name=TTWO) (Game developer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191723)
(2025-08-07, After Market Close):
- Revenue +12.4% YoY (vs +13.2% in previous quarter and historical rate +17.6%)
- EBITDA margin 4.5% increased compared to -7.4% same period last year
- Net Debt decreased by $1.2 bln since the start of the year (3.0% of market cap)
- FCF (LTM) +$1.6 bln (positive), 4.0% of market cap
- EV/Sales multiple is 7x
At the opening of the session the share price went up +4.9% vs S&P500 +0.2%
------------------------------------------------
#reports #TPR
[Tapestry](https://eninvs.com/all.php?name=TPR) (Clothes seller) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191520)
(2025-08-14, Before Market Open):
- Revenue -74.2% YoY (vs +7.0% in previous quarter and historical rate +5.7%)
- EBITDA -62.3% YoY (vs +20.1% in previous quarter and historical rate +3.7%)
- EBITDA margin 28.8% increased compared to 19.7% same period last year
- Net Debt decreased by $271 mln over the past reporting period (1.2% of market cap)
- EV/EBITDA multiple is 19.6x compared to historical level (75th percentile) of 8.4x
- EV/Sales multiple is 4.7x
At the opening of the session the share price went down -15.5% vs S&P500 -0.2%
------------------------------------------------
#reports #SPTN
[SpartanNash](https://eninvs.com/all.php?name=SPTN) (Food Distribution) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191519)
(2025-08-14, Before Market Open):
- Revenue +1.8% YoY (vs +3.7% in previous quarter and historical rate +1.9%)
- EBITDA -30.2% YoY (vs -83.0% in previous quarter and historical rate +0.9%)
- EBITDA margin 1.6% decreased compared to 2.4% same period last year
- Net Debt decreased by $48 mln over the past reporting period (5.4% of market cap)
- FCF (LTM) -$0.2 bln (negative), 21.3% of market cap
- EV/EBITDA multiple is 14.1x compared to historical level (75th percentile) of 6.8x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went up +0.1% vs S&P500 -0.2%
------------------------------------------------
#reports #VIPS
@ china
[Vipshop](https://eninvs.com/all.php?name=VIPS) (E-commerce platform) reported for 2025 q2
(2025-08-14, Before Market Open):
- Revenue -2.6% YoY (vs -5.5% in previous quarter and historical rate -1.1%)
- EBITDA -24.3% YoY (vs -19.3% in previous quarter and historical rate +15.0%)
- EBITDA margin 6.1% decreased compared to 7.9% same period last year
- Net Debt increased by $463 mln over the past reporting period (4.4% of market cap)
- FCF (LTM) +$0.5 bln (positive), 4.6% of market cap
- EV/EBITDA multiple is 7.7x compared to historical level (75th percentile) of 7.3x
- EV/Sales multiple is 0.5x
At the opening of the session the share price went up +4.8% vs S&P500 -0.2%
------------------------------------------------
#reports #NTES
@ china
[NetEase](https://eninvs.com/all.php?name=NTES) (IT services and products provider) reported for 2025 q2
(2025-08-14, Before Market Open):
- Revenue +11% YoY (vs +6.8% in previous quarter and historical rate +5.0%)
- EBITDA +26.3% YoY (vs +32.7% in previous quarter and historical rate +13.2%)
- EBITDA margin 34.0% increased compared to 29.9% same period last year
- Net Debt decreased by $874 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$3.7 bln (positive), 4.3% of market cap
- EV/EBITDA multiple is 13.4x compared to historical level (75th percentile) of 14.1x
- EV/Sales multiple is 4.5x
At the opening of the session the share price went down -8.8% vs S&P500 -0.2%
------------------------------------------------
#reports #VRME
[VerifyMe](https://eninvs.com/all.php?name=VRME) (Security and Protection Services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191508)
(2025-08-13, Before Market Open):
- Revenue 0% YoY (vs -33.3% in previous quarter and historical rate +47.8%)
- EBITDA 0% YoY (vs 0.0% in previous quarter)
- EBITDA margin 60.0% has not changed compared to 60.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (10.3% of market cap)
- FCF (LTM) +$0 bln (positive), 62.0% of market cap
- EV/EBITDA multiple is 0.4x compared to historical level (75th percentile) of 1.4x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went up +9.2% vs S&P500 +0.3%
------------------------------------------------
#reports #RRGB
[Red Robin Gourmet Burgers](https://eninvs.com/all.php?name=RRGB) (Restaurant chain owner) reported for 2025 q2
(2025-08-13, After Market Close):
- Revenue -5.3% YoY (vs +0.8% in previous quarter and historical rate 0.0%)
- EBITDA +133.3% YoY (vs +50.0% in previous quarter and historical rate -2.0%)
- EBITDA margin 7.4% increased compared to 3.0% same period last year
- Net Debt decreased by $21 mln over the past reporting period (19.9% of market cap)
- FCF (LTM) +$0 bln (positive), 33.2% of market cap
- EV/EBITDA multiple is 54.9x compared to historical level (75th percentile) of 36.1x
- EV/Sales multiple is 0.5x
------------------------------------------------
#reports #KE
[Kimball Electronics](https://eninvs.com/all.php?name=KE) (Electrical Equipment and Parts) reported for 2025 q2
(2025-08-13, After Market Close):
- Revenue -11.6% YoY (vs -11.8% in previous quarter and historical rate +5.6%)
- EBITDA -15% YoY (vs +1500.0% in previous quarter and historical rate +31.3%)
- EBITDA margin 4.5% decreased compared to 4.7% same period last year
- Net Debt decreased by $69 mln over the past reporting period (13.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 17.4% of market cap
- EV/EBITDA multiple is 12x compared to historical level (75th percentile) of 13.2x
- EV/Sales multiple is 0.4x
------------------------------------------------
#reports #GWRS
[Global Water Resources](https://eninvs.com/all.php?name=GWRS) (Utilities — Regulated Water) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191502)
(2025-08-13, Before Market Open):
- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +16.1%)
- EBITDA 0% YoY (vs +25.0% in previous quarter and historical rate +16.4%)
- EBITDA margin 42.9% has not changed compared to 42.9% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.8% of market cap)
- EV/EBITDA multiple is 17.7x compared to historical level (75th percentile) of 19.6x
- EV/Sales multiple is 5.7x
At the opening of the session the share price went down -0.2% vs S&P500 +0.3%
------------------------------------------------
#reports #GLBE
[Global-e Online Ltd.](https://eninvs.com/all.php?name=GLBE) (Internet Retail) reported for 2025 q2
(2025-08-13, Before Market Open):
- Revenue +28% YoY (vs +30.1% in previous quarter and historical rate +34.8%)
- EBITDA margin 5.1% increased compared to -13.1% same period last year
- Net Debt decreased by $70 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.5% of market cap
- EV/Sales multiple is 5.2x
At the opening of the session the share price went up +8.7% vs S&P500 +0.3%
------------------------------------------------
#reports #EWCZ
[European Wax Center, Inc.](https://eninvs.com/all.php?name=EWCZ) (Household and Personal Products) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191501)
(2025-08-13, Before Market Open):
- Revenue -6.7% YoY (vs -1.9% in previous quarter and historical rate +18.7%)
- EBITDA 0% YoY (vs 0.0% in previous quarter and historical rate +28.9%)
- EBITDA margin 33.9% increased compared to 31.7% same period last year
- Net Debt decreased by $4 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0 bln (positive), 2.1% of market cap
- EV/EBITDA multiple is 10x compared to historical level (75th percentile) of 22.6x
- EV/Sales multiple is 3.2x
At the opening of the session the share price went up +10.7% vs S&P500 +0.3%
------------------------------------------------
#reports #ESLT
[Elbit Systems](https://eninvs.com/all.php?name=ESLT) (Aerospace and Defense) reported for 2025 q2
(2025-08-13, Before Market Open):
- Revenue +21.3% YoY (vs +22.0% in previous quarter and historical rate +11.1%)
- EBITDA +29.7% YoY (vs +32.4% in previous quarter and historical rate +13.3%)
- EBITDA margin 10.2% increased compared to 9.5% same period last year
- Net Debt decreased by $148 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 29.2x compared to historical level (75th percentile) of 21.9x
- EV/Sales multiple is 2.9x
At the opening of the session the share price went up +7.0% vs S&P500 +0.3%
------------------------------------------------
#reports #CDXS
[Codexis](https://eninvs.com/all.php?name=CDXS) (Biotechnology) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191497)
(2025-08-13, After Market Close):
- Revenue +87.5% YoY (vs -52.9% in previous quarter and historical rate -12.8%)
- EBITDA margin -80.0% increased compared to -275.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0 bln (negative), 7.0% of market cap
- EV/Sales multiple is 3.5x
------------------------------------------------
#reports #CAAS
[China Automotive Systems](https://eninvs.com/all.php?name=CAAS) (Auto Parts) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191496)
(2025-08-13, Before Market Open):
- Revenue +10.7% YoY (vs +20.1% in previous quarter and historical rate +11.5%)
- EBITDA +6.3% YoY (vs -13.3% in previous quarter and historical rate +20.8%)
- EBITDA margin 9.7% decreased compared to 10.1% same period last year
- Net Debt decreased by $12 mln over the past reporting period (9.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 49.3% of market cap
- EV/EBITDA multiple is 1.9x compared to historical level (75th percentile) of 2.1x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went up +3.6% vs S&P500 +0.3%
------------------------------------------------
#reports #ARAY
[Accuray](https://eninvs.com/all.php?name=ARAY) (Medical Devices) reported for 2025 q2
(2025-08-13, After Market Close):
- Revenue -62.9% YoY (vs +11.9% in previous quarter and historical rate +12.8%)
- EBITDA -37.5% YoY (vs +600.0% in previous quarter and historical rate +21.9%)
- EBITDA margin 3.9% increased compared to 2.3% same period last year
- Net Debt decreased by $10 mln over the past reporting period (6.6% of market cap)
- FCF (LTM) +$0 bln (positive), 3.3% of market cap
- EV/EBITDA multiple is 17.4x compared to historical level (75th percentile) of 320x
- EV/Sales multiple is 0.6x
------------------------------------------------
#reports #XTNT
[Xtant Medical](https://eninvs.com/all.php?name=XTNT) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191493)
(2025-08-12, Before Market Open):
- Revenue +16.7% YoY (vs +17.9% in previous quarter and historical rate +34.2%)
- EBITDA margin 17.1% increased compared to -6.7% same period last year
- Net Debt decreased by $1 mln over the past reporting period (1.1% of market cap)
- EV/Sales multiple is 0.9x
At the opening of the session the share price went up +12.4% vs S&P500 +0.3%
------------------------------------------------
#reports #TBPH
[Theravance Biopharma](https://eninvs.com/all.php?name=TBPH) (Biotechnology) reported for 2025 q2
(2025-08-12, After Market Close):
- Revenue +85.7% YoY (vs 0.0% in previous quarter and historical rate +32.7%)
- EBITDA margin -11.5% increased compared to -114.3% same period last year
- Net Debt decreased by $209 mln over the past reporting period (23.8% of market cap)
- FCF (LTM) +$0 bln (positive), 4.6% of market cap
- EV/EBITDA multiple is 287.1x compared to historical level (75th percentile) of 230.3x
- EV/Sales multiple is 7.5x
------------------------------------------------
#reports #SSTI
[ShotSpotter](https://eninvs.com/all.php?name=SSTI) (Software — Application) reported for 2025 q2
(2025-08-12, After Market Close):
- Revenue -3.7% YoY (vs +12.0% in previous quarter and historical rate +20.2%)
- EBITDA margin -11.5% decreased compared to 0.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0 bln (positive), 2.9% of market cap
- EV/Sales multiple is 1.3x
------------------------------------------------
#reports #SMWB
[Similarweb Ltd.](https://eninvs.com/all.php?name=SMWB) (Internet Content and Information) reported for 2025 q2
(2025-08-12, After Market Close):
- Revenue +16.4% YoY (vs +13.6% in previous quarter and historical rate +14.3%)
- EBITDA -350% YoY (vs -1000.0% in previous quarter)
- EBITDA margin -7.0% decreased compared to 3.3% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0 bln (negative), 0.7% of market cap
- EV/Sales multiple is 1.9x
------------------------------------------------
#reports #REKR
[Rekor Systems](https://eninvs.com/all.php?name=REKR) (Software — Infrastructure) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191488)
(2025-08-12, After Market Close):
- Revenue 0% YoY (vs -10.0% in previous quarter and historical rate +54.5%)
- EBITDA margin -58.3% increased compared to -75.0% same period last year
- EV/Sales multiple is 1.5x
------------------------------------------------
#reports #QUIK
[QuickLogic Corporation](https://eninvs.com/all.php?name=QUIK) (Semiconductors) reported for 2025 q2
(2025-08-12, After Market Close):
- Revenue 0% YoY (vs -33.3% in previous quarter and historical rate +11.3%)
- EBITDA margin -75.0% decreased compared to -50.0% same period last year
- Net Debt decreased by $4 mln over the past reporting period (4.5% of market cap)
- FCF (LTM) -$0 bln (negative), 1.1% of market cap
- EV/Sales multiple is 4.8x
------------------------------------------------
#reports #PXLW
[Pixelworks](https://eninvs.com/all.php?name=PXLW) (Semiconductors) reported for 2025 q2
(2025-08-12, After Market Close):
- Revenue -11.1% YoY (vs -56.3% in previous quarter and historical rate -14.7%)
- EBITDA margin -75.0% increased compared to -100.0% same period last year
- Net Debt increased by $4 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0 bln (negative), 0.9% of market cap
- EV/Sales multiple is 18.1x
------------------------------------------------
#reports #NPCE
[NeuroPace, Inc.](https://eninvs.com/all.php?name=NPCE) (Medical Devices) reported for 2025 q2
(2025-08-12, After Market Close):
- Revenue +26.3% YoY (vs +27.8% in previous quarter and historical rate +44.6%)
- EBITDA margin -29.2% increased compared to -31.6% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 4.9% of market cap
- EV/Sales multiple is 1.7x
------------------------------------------------
#reports #IRIX
[IRIDEX Corporation](https://eninvs.com/all.php?name=IRIX) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191481)
(2025-08-12, After Market Close):
- Revenue +7.7% YoY (vs 0.0% in previous quarter and historical rate -0.7%)
- EBITDA margin -7.1% increased compared to -15.4% same period last year
- Net Debt decreased by $34 mln over the past reporting period (156.4% of market cap)
- FCF (LTM) -$0 bln (negative), 193.1% of market cap
- EV/Sales multiple is 0.5x
------------------------------------------------
#reports #INTA
[Intapp, Inc.](https://eninvs.com/all.php?name=INTA) (Software — Application) reported for 2025 q2
(2025-08-12, After Market Close):
- Revenue +18.4% YoY (vs +16.2% in previous quarter and historical rate +22.9%)
- EBITDA -100% YoY (vs -300.0% in previous quarter and historical rate +8.3%)
- Net Debt increased by $10 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.7% of market cap
- EV/Sales multiple is 4x
------------------------------------------------
#reports #IDN
[Intellicheck](https://eninvs.com/all.php?name=IDN) (Software — Application) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191480)
(2025-08-12, After Market Close):
- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +26.1%)
- Net Debt decreased by $4 mln over the past reporting period (4.2% of market cap)
- FCF (LTM) -$0 bln (negative), 2.1% of market cap
- EV/Sales multiple is 2.9x
------------------------------------------------
#reports #FTHM
[Fathom](https://eninvs.com/all.php?name=FTHM) (Real Estate Services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191478)
(2025-08-12, After Market Close):
- Revenue +536.8% YoY (vs +31.0% in previous quarter and historical rate +7.5%)
- EBITDA -120% YoY (vs -400.0% in previous quarter)
- EBITDA margin -0.8% decreased compared to 26.3% same period last year
- Net Debt increased by $3 mln over the past reporting period (8.9% of market cap)
- FCF (LTM) -$0 bln (negative), 17.8% of market cap
- EV/Sales multiple is 0.1x
------------------------------------------------
#reports #DRIO
[DarioHealth](https://eninvs.com/all.php?name=DRIO) (Diagnostics and Research) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191477)
(2025-08-12, Before Market Open):
- Revenue -16.7% YoY (vs +16.7% in previous quarter and historical rate +25.2%)
- EBITDA -47.1% YoY (vs -44.4% in previous quarter and historical rate +65.9%)
- EBITDA margin 180.0% decreased compared to 283.3% same period last year
- Net Debt decreased by $11 mln over the past reporting period (112.3% of market cap)
- FCF (LTM) +$0 bln (positive), 459.6% of market cap
- EV/Sales multiple is -1.3x
At the opening of the session the share price went down -10.5% vs S&P500 +0.3%
------------------------------------------------
#reports #DERM
[Journey Medical Corporation](https://eninvs.com/all.php?name=DERM) (Drug Manufacturers — Specialty and Generic) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191476)
(2025-08-12, After Market Close):
- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate -7.6%)
- EBITDA margin -20.0% has not changed compared to -20.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0 bln (negative), 4.6% of market cap
- EV/Sales multiple is 3.2x
------------------------------------------------
#reports #AP
[Ampco-Pittsburgh Corporation](https://eninvs.com/all.php?name=AP) (Metal Fabrication) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191470)
(2025-08-12, After Market Close):
- Revenue +1.8% YoY (vs -5.5% in previous quarter and historical rate +4.9%)
- EBITDA -80% YoY (vs +60.0% in previous quarter and historical rate +51.2%)
- EBITDA margin 1.8% decreased compared to 9.0% same period last year
- Net Debt increased by $5 mln over the past reporting period (7.4% of market cap)
- EV/EBITDA multiple is 1.2x compared to historical level (75th percentile) of 10.9x
- EV/Sales multiple is 0.5x
------------------------------------------------
#reports #SE
@ gaming
[Sea](https://eninvs.com/all.php?name=SE) (Electronic Gaming and Multimedia) reported for 2025 q2
(2025-08-12, Before Market Open):
- Revenue +38.1% YoY (vs +29.6% in previous quarter and historical rate +18.8%)
- EBITDA +279.3% YoY (vs +303.1% in previous quarter and historical rate +99.1%)
- EBITDA margin 10.5% increased compared to 3.8% same period last year
- Net Debt decreased by $941 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$2.5 bln (positive), 2.5% of market cap
- EV/EBITDA multiple is 58.6x compared to historical level (75th percentile) of 136.2x
- EV/Sales multiple is 4.8x
At the opening of the session the share price went up +13.9% vs S&P500 +0.3%
------------------------------------------------
#reports #HUYA
@ china , @ gaming
[HUYA](https://eninvs.com/all.php?name=HUYA) (Entertainment) reported for 2025 q2
(2025-08-12, Before Market Open):
- Revenue +3.3% YoY (vs 0.0% in previous quarter and historical rate -15.9%)
- EBITDA margin -1.4% has not changed compared to -1.4% same period last year
- Net Debt increased by $236 mln over the past reporting period (28.6% of market cap)
- FCF (LTM) -$0.2 bln (negative), 21.3% of market cap
- EV/EBITDA multiple is 6x compared to historical level (75th percentile) of 3.4x
- EV/Sales multiple is 0.4x
------------------------------------------------
#reports #TELA
[TELA Bio](https://eninvs.com/all.php?name=TELA) (Medical Devices) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191456)
(2025-08-11, After Market Close):
- Revenue +25% YoY (vs +11.8% in previous quarter and historical rate +31.7%)
- EBITDA margin -45.0% increased compared to -68.8% same period last year
- Net Debt decreased by $30 mln over the past reporting period (40.2% of market cap)
- FCF (LTM) +$0 bln (positive), 21.5% of market cap
- EV/Sales multiple is 0.6x
------------------------------------------------
#reports #QRHC
[Quest Resource Corporation](https://eninvs.com/all.php?name=QRHC) (Waste Management) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191452)
(2025-08-11, After Market Close):
- Revenue -17.8% YoY (vs -6.8% in previous quarter and historical rate +12.4%)
- EBITDA -50% YoY (vs -250.0% in previous quarter)
- EBITDA margin 3.3% decreased compared to 5.5% same period last year
- Net Debt decreased by $3 mln over the past reporting period (7.3% of market cap)
- FCF (LTM) +$70.9 bln (positive), 173543.3% of market cap
- EV/Sales multiple is 0.4x
------------------------------------------------
#reports #PUBM
[PubMatic, Inc.](https://eninvs.com/all.php?name=PUBM) (Software — Application) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191451)
(2025-08-11, After Market Close):
- Revenue +6% YoY (vs -4.5% in previous quarter and historical rate +5.5%)
- EBITDA -14.3% YoY (vs -100.0% in previous quarter and historical rate +3.4%)
- EBITDA margin 8.5% decreased compared to 10.4% same period last year
- Net Debt increased by $27 mln over the past reporting period (5.3% of market cap)
- FCF (LTM) -$0 bln (negative), 8.6% of market cap
- EV/EBITDA multiple is 6.2x compared to historical level (75th percentile) of 11.2x
- EV/Sales multiple is 1.5x
------------------------------------------------
#reports #OMI
[Owens & Minor](https://eninvs.com/all.php?name=OMI) (Logistic services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191447)
(2025-08-11, Before Market Open):
- Revenue -74.5% YoY (vs +0.7% in previous quarter and historical rate -3.4%)
- EBITDA -76.2% YoY (vs -27.4% in previous quarter and historical rate -17.7%)
- EBITDA margin 2.9% decreased compared to 3.1% same period last year
- Net Debt decreased by $192 mln over the past reporting period (65.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 24.9% of market cap
- EV/Sales multiple is 0.3x
At the opening of the session the share price went down -16.5% vs S&P500 0.0%
------------------------------------------------
#reports #NGS
[Natural Gas Services Group](https://eninvs.com/all.php?name=NGS) (Oil and Gas Equipment and Services) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191446)
(2025-08-11, After Market Close):
- Revenue +7.9% YoY (vs +10.8% in previous quarter and historical rate +38.6%)
- EBITDA +18.8% YoY (vs +12.5% in previous quarter and historical rate +65.8%)
- EBITDA margin 46.3% increased compared to 42.1% same period last year
- Net Debt increased by $16 mln over the past reporting period (5.1% of market cap)
- FCF (LTM) -$0 bln (negative), 7.3% of market cap
- EV/EBITDA multiple is 5.8x compared to historical level (75th percentile) of 8.9x
- EV/Sales multiple is 2.5x
------------------------------------------------
#reports #MRCY
[Mercury Systems](https://eninvs.com/all.php?name=MRCY) (Aerospace and Defense) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191443)
(2025-08-11, After Market Close):
- Revenue -56.5% YoY (vs +1.4% in previous quarter and historical rate +5.0%)
- EBITDA margin 16.1% increased compared to -5.7% same period last year
- Net Debt decreased by $42 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$0 bln (positive), 1.3% of market cap
- EV/EBITDA multiple is 54.4x compared to historical level (75th percentile) of 34.6x
- EV/Sales multiple is 3.8x
------------------------------------------------
#reports #MNDY
[monday.com Ltd.](https://eninvs.com/all.php?name=MNDY) (Software — Application) reported for 2025 q2
(2025-08-11, Before Market Open):
- Revenue +26.7% YoY (vs +30.0% in previous quarter and historical rate +39.7%)
- EBITDA -500% YoY (vs +1200.0% in previous quarter and historical rate +50.0%)
- EBITDA margin -2.7% decreased compared to 0.8% same period last year
- Net Debt decreased by $58 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.2 bln (positive), 2.2% of market cap
- EV/Sales multiple is 5.5x
At the opening of the session the share price went down -24.1% vs S&P500 0.0%
------------------------------------------------
#reports #LPSN
[LivePerson](https://eninvs.com/all.php?name=LPSN) (Software provider) reported for 2025 q2
(2025-08-11, After Market Close):
- Revenue -25% YoY (vs -23.5% in previous quarter and historical rate -14.9%)
- EBITDA margin -1.7% increased compared to -65.0% same period last year
- Net Debt increased by $23 mln over the past reporting period (21.1% of market cap)
- FCF (LTM) -$0 bln (negative), 27.5% of market cap
- EV/Sales multiple is 1.8x
------------------------------------------------
#reports #GPRO
[GoPro](https://eninvs.com/all.php?name=GPRO) (Technological equipment manufacturer) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191430)
(2025-08-11, After Market Close):
- Revenue +257% YoY (vs -13.5% in previous quarter and historical rate +4.3%)
- EBITDA margin -9.3% increased compared to -24.2% same period last year
- Net Debt decreased by $12 mln over the past reporting period (6.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 41.4% of market cap
- EV/Sales multiple is 0.2x
------------------------------------------------
#reports #GPRE
[Green Plains](https://eninvs.com/all.php?name=GPRE) (Specialty Chemicals) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191429)
(2025-08-11, Before Market Open):
- Revenue -10.7% YoY (vs +0.8% in previous quarter and historical rate -8.8%)
- EBITDA -125% YoY (vs -4100.0% in previous quarter)
- EBITDA margin -0.2% decreased compared to 0.6% same period last year
- Net Debt decreased by $82 mln over the past reporting period (14.5% of market cap)
- FCF (LTM) -$0 bln (negative), 7.4% of market cap
- EV/EBITDA multiple is 21.8x compared to historical level (75th percentile) of 77.7x
- EV/Sales multiple is 0.4x
At the opening of the session the share price went up +9.7% vs S&P500 0.0%
------------------------------------------------
#reports #ENTA
[Enanta Pharmaceuticals](https://eninvs.com/all.php?name=ENTA) (Small molecular drugs manufacturer) reported for 2025 q2
(2025-08-11, After Market Close):
- Revenue 0% YoY (vs -11.8% in previous quarter and historical rate -1.7%)
- EBITDA margin -100.0% increased compared to -127.8% same period last year
- Net Debt decreased by $12 mln over the past reporting period (8.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 63.5% of market cap
- EV/Sales multiple is -0.1x
------------------------------------------------
#reports #EE
[Excelerate Energy, Inc.](https://eninvs.com/all.php?name=EE) (Utilities — Renewable) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191424)
(2025-08-11, Before Market Open):
- Revenue +12% YoY (vs +57.5% in previous quarter and historical rate -16.6%)
- EBITDA -13.7% YoY (vs +27.9% in previous quarter and historical rate +20.5%)
- EBITDA margin 33.7% decreased compared to 43.7% same period last year
- Net Debt increased by $1 bln since the start of the year (40.1% of market cap)
- FCF (LTM) -$0 bln (negative), 0.6% of market cap
- EV/EBITDA multiple is 15.8x compared to historical level (75th percentile) of 14.1x
- EV/Sales multiple is 5.2x
At the opening of the session the share price went up +0.1% vs S&P500 0.0%
------------------------------------------------
#reports #DDD
[3D Systems Corporation](https://eninvs.com/all.php?name=DDD) (3D printing services provider) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191422)
(2025-08-11, After Market Close):
- Revenue -15.9% YoY (vs -7.8% in previous quarter and historical rate -10.6%)
- EBITDA margin -12.6% increased compared to -15.9% same period last year
- Net Debt decreased by $73 mln over the past reporting period (31.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 25.7% of market cap
- EV/EBITDA multiple is 0.9x compared to historical level (75th percentile) of 2.4x
- EV/Sales multiple is 0.7x
------------------------------------------------
#reports #CEVA
[CEVA](https://eninvs.com/all.php?name=CEVA) (Wireless and intelligent sensor platforms licensor ) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191420)
(2025-08-11, Before Market Open):
- Revenue -7.1% YoY (vs +9.1% in previous quarter and historical rate -6.1%)
- EBITDA margin -15.4% decreased compared to 3.6% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.2% of market cap)
- EV/Sales multiple is 3.3x
At the opening of the session the share price went up +7.3% vs S&P500 0.0%
------------------------------------------------
#reports #CE
[Celanese](https://eninvs.com/all.php?name=CE) (Chemicals manufacturer ) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191419)
(2025-08-11, After Market Close):
- Revenue -4.5% YoY (vs -8.5% in previous quarter and historical rate +1.7%)
- EBITDA -6.8% YoY (vs -19.9% in previous quarter and historical rate -18.4%)
- EBITDA margin 12.9% decreased compared to 13.2% same period last year
- Net Debt decreased by $55 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.6% of market cap
- EV/Sales multiple is 1.8x
------------------------------------------------
#reports #BW
[Babcock & Wilcox Enterprises](https://eninvs.com/all.php?name=BW) (Specialty Industrial Machinery) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191417)
(2025-08-11, After Market Close):
- Revenue -38.5% YoY (vs -13.0% in previous quarter and historical rate +18.7%)
- EBITDA -81.4% YoY (vs +20.0% in previous quarter)
- EBITDA margin 5.6% decreased compared to 18.4% same period last year
- Net Debt decreased by $20 mln over the past reporting period (17.7% of market cap)
- FCF (LTM) -$0.2 bln (negative), 183.6% of market cap
- EV/EBITDA multiple is 85.7x compared to historical level (75th percentile) of 55.2x
- EV/Sales multiple is 0.4x
------------------------------------------------
#reports #ASRT
[Assertio](https://eninvs.com/all.php?name=ASRT) (Drug Manufacturers — Specialty and Generic) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191416)
(2025-08-11, After Market Close):
- Revenue -6.5% YoY (vs -18.8% in previous quarter and historical rate +7.8%)
- EBITDA -66.7% YoY (vs -500.0% in previous quarter and historical rate -46.5%)
- EBITDA margin 3.4% decreased compared to 9.7% same period last year
- Net Debt decreased by $11 mln over the past reporting period (31.7% of market cap)
- FCF (LTM) -$0 bln (negative), 5.8% of market cap
- EV/EBITDA multiple is 0.9x compared to historical level (75th percentile) of 3.2x
- EV/Sales multiple is -0.2x
------------------------------------------------
#reports #ARIS
[Aris Water Solutions, Inc.](https://eninvs.com/all.php?name=ARIS) (Utilities — Regulated Water) reported for [2025 q2](https://eninvs.com/press_release.php?source=sec&form_type=10&id=191415)
(2025-08-11, After Market Close):
- Revenue +22.8% YoY (vs +16.5% in previous quarter and historical rate +21.0%)
- EBITDA +4.5% YoY (vs +2.1% in previous quarter and historical rate +42.6%)
- EBITDA margin 37.1% decreased compared to 43.6% same period last year
- Net Debt decreased by $27 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) -$0 bln (negative), 3.5% of market cap
- EV/EBITDA multiple is 8.2x compared to historical level (75th percentile) of 9.2x
- EV/Sales multiple is 3.2x
